Merz Asks UPC To Bar Viatris Generic MS Drug
Pharmaceutical giant Merz has sued generic-drug maker Viatris and asked Europe's patent court for a preliminary injunction as it fights to protect a soon-to-expire patented treatment for multiple sclerosis. ...To view the full article, register now.
Already a subscriber? Click here to view full article